BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1732556)

  • 1. Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
    Montgomery JA; Shortnacy-Fowler AT; Clayton SD; Riordan JM; Secrist JA
    J Med Chem; 1992 Jan; 35(2):397-401. PubMed ID: 1732556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluations of certain 2-halo-2'-substituted derivatives of 9-beta-D-arabinofuranosyladenine.
    Secrist JA; Shortnacy AT; Montgomery JA
    J Med Chem; 1988 Feb; 31(2):405-10. PubMed ID: 3339610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
    Lee SH; Thomas LK; Unger FM; Christian R; Sartorelli AC
    Int J Cancer; 1981 May; 27(5):703-8. PubMed ID: 6974703
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
    Phadtare S; Kessel D; Corbett TH; Renis HE; Court BA; Zimlicka J
    J Med Chem; 1991 Jan; 34(1):421-9. PubMed ID: 1992143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines.
    McNamara DJ; Cook PD
    J Med Chem; 1987 Feb; 30(2):340-7. PubMed ID: 3806615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral and cytotoxic activity of iodohydrin and iodomethoxy derivatives of 5-vinyl-2'-deoxyuridines, 2'-fluoro-2'-deoxyuridine, and uridine.
    Kumar R; Xu LH; Knaus EE; Wiebe LI; Tovell DR; Tyrrell DL; Allen TM
    J Med Chem; 1990 Feb; 33(2):717-23. PubMed ID: 2299637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrugs of 9-beta-D-arabinofuranosyladenine. 1. Synthesis and evaluation of some 5'-(O-acyl) derivatives.
    Baker DC; Haskell TH; Putt SR
    J Med Chem; 1978 Dec; 21(12):1218-21. PubMed ID: 722731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Substituted derivatives of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine.
    Montgomery JA; Shortnacy AT; Arnett G; Shannon WM
    J Med Chem; 1977 Mar; 20(3):401-4. PubMed ID: 191611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP production.
    Huang P; Plunkett W
    Biochem Pharmacol; 1987 Sep; 36(18):2945-50. PubMed ID: 3307790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.
    Brockman RW; Schabel FM; Montgomery JA
    Biochem Pharmacol; 1977 Nov; 26(22):2193-6. PubMed ID: 563233
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W; Chubb S; Alexander L; Montgomery JA
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
    Dow LW; Bell DE; Poulakos L; Fridland A
    Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and tumor uptake of 5-halo-1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)[2-14C]uracils.
    Mercer JR; Knaus EE; Wiebe LI
    J Med Chem; 1987 Apr; 30(4):670-5. PubMed ID: 2951522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
    Avramis VI; Plunkett W
    Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Methylpurine derived sugar modified nucleosides: Synthesis and evaluation of their substrate activity with purine nucleoside phosphorylases.
    Hassan AE; Abou-Elkhair RA; Parker WB; Allan PW; Secrist JA
    Bioorg Chem; 2016 Apr; 65():9-16. PubMed ID: 26745284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)adenine (Cl-F-ara-A).
    Waud WR; Schmid SM; Montgomery JA; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):447-60. PubMed ID: 10772726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.